Stock Events

Stock Events

Qiagen NV 

$43.47
89
-$0.39-0.89% 20:00 Today

Statistics

Day High
43.66
Day Low
42.79
52W High
57.82
52W Low
32.53
Volume
1,922,186
Avg. Volume
2,881,182
Mkt Cap
8.98B
P/E Ratio
21.18
Dividend Yield
0.81%
Dividend
0.35

Upcoming

Dividends

0.81%Dividend Yield
Jul 26
$0.35
Jan 26
$2.41
Jul 25
$0.26
Jul 25
$0.26
Jan 25
$1.33
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
37.48%

Earnings

10NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
0.5
0.55
0.6
0.64
Expected EPS
0.618805
Actual EPS
N/A

Financials

20.91%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
2.09BRevenue
436.97MNet Income

Analyst Ratings

42.88Average Price Target
The highest estimate is 54.00.
From 8 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
50%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow QGEN. It's not an investment recommendation.
AMD
14
AMD
Microsoft
13
MSFT
Apple
12
AAPL
NVIDIA
12
NVDA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap32.55B
Illumina provides sequencing and array-based solutions for genetic analysis, directly competing in the genomics space with Qiagen's sample and assay technologies.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific offers a broad range of reagents, instruments, and consumables used in biological and medical research, competing with Qiagen in multiple areas including sample preparation and diagnostics.
Bio-Rad Laboratories
BIO
Mkt Cap10.37B
Bio-Rad Laboratories offers products and systems used to separate complex chemical and biological materials, directly competing with Qiagen in the life sciences research market.
Agilent Technologies
A
Mkt Cap43.38B
Agilent Technologies provides instruments, services, consumables, applications, and expertise, focusing on the life sciences, diagnostics, and applied chemical markets, competing with Qiagen in diagnostics and research.
Pacific Biosciences of California
PACB
Mkt Cap435.16M
Pacific Biosciences offers sequencing systems that compete with Qiagen's genomic and DNA sequencing solutions.
Repligen
RGEN
Mkt Cap9.95B
Repligen Corporation provides bioprocessing technologies and systems that compete with Qiagen's solutions for the purification and isolation of biological samples and substances.
Bio-Rad Laboratories
BIO.B
Mkt Cap8.84B
Bio-Rad Laboratories, through its Class B shares, competes in the same space as its Class A shares, offering similar products and technologies that rival Qiagen's offerings.
Quest Diagnostics
DGX
Mkt Cap26.79B
Quest Diagnostics provides diagnostic testing, information, and services, competing with Qiagen in the diagnostics and molecular diagnostics markets.
Guardant Health
GH
Mkt Cap21.67B
Guardant Health focuses on liquid biopsies and cancer diagnostics, competing with Qiagen in the precision medicine and cancer diagnostics space.

About

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables, with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by Europe, the Middle East, and Africa (33%) and Asia-Pacific (15%).
Show more...
CEO
Thierry Bernard
Employees
5500
Country
Netherlands
ISIN
NL0015002SN0
WKN
000A41HBE

Listings

F
DE
QIA.F
STU
DE
QIA.STU
MU
DE
QIA.MU
XNYS
US
QGEN

0 Comments

Share your thoughts

FAQ

What is Qiagen NV stock price today?▼
The current price of QGEN is $43.47 USD — it has decreased by -0.89% in the past 24 hours. Watch Qiagen NV stock price performance more closely on the chart.
What is Qiagen NV stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNYS exchange Qiagen NV stocks are traded under the ticker QGEN.
Is Qiagen NV stock price growing?▼
QGEN stock has risen by +0.84% compared to the previous week, the month change is a +2.69% rise, over the last year Qiagen NV has showed a -12.21% decrease.
What is Qiagen NV market cap?▼
Today Qiagen NV has the market capitalization of 8.98B
When is the next Qiagen NV earnings date?▼
Qiagen NV is going to release the next earnings report on November 10, 2026.
What were Qiagen NV earnings last quarter?▼
QGEN earnings for the last quarter are 0.62 USD per share, whereas the estimation was 0.6 USD resulting in a +3.61% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Qiagen NV revenue for the last year?▼
Qiagen NV revenue for the last year amounts to 2.09B USD.
What is Qiagen NV net income for the last year?▼
QGEN net income for the last year is 436.97M USD.
Does Qiagen NV pay dividends?▼
Yes, QGEN dividends are paid annual. The last dividend per share was 0.35 USD. As of today, Dividend Yield (FWD)% is 0.81%.
How many employees does Qiagen NV have?▼
As of September 04, 2026, the company has 5,500 employees.
In which sector is Qiagen NV located?▼
Qiagen NV operates in the Health & Wellness sector.
When did Qiagen NV complete a stock split?▼
The last stock split for Qiagen NV was on January 08, 2026 with a ratio of 19:20.
Where is Qiagen NV headquartered?▼
Qiagen NV is headquartered in Venlo, Netherlands.